Chit Laa Poh (Chitlaa Poh)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 44

Top Venues

Viruses

International journal of molecular sciences

Vaccines

Pharmaceutics

Sunway University

Monash University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sunway University Mar 18 2011

Malaysia

Distinguished Professor :: Vice Chancellor's Office

Education History

Monash University Feb 05 1976 - Jul 30 1980

Australia

PHD :: Microbiology

Publications

Kanwal Khalid, Hui Xuan Lim, Ayaz Anwar, Soon Hao Tan, Jung Shan Hwang, Seng-Kai Ong, Chit Laa Poh
Preclinical Development of a Novel Epitope-based DNA Vaccine Candidate against SARS-CoV-2 and Evaluation of Immunogenicity in BALB/c Mice. AAPS PharmSciTech 25 (3) (2024)
Kanwal Khalid, Hui Xuan Lim, Jung Shan Hwang, Chit Laa Poh
The Development of Epitope-Based Recombinant Protein Vaccines against SARS-CoV-2. The AAPS journal 26 (5) (2024)
Kanwal Khalid, Hui Xuan Lim, Ayaz Anwar, Soon Hao Tan, Jung Shan Hwang, Seng-Kai Ong, Chit Laa Poh
Preclinical Development of a Novel Epitope-based DNA Vaccine Candidate against SARS-CoV-2 and Evaluation of Immunogenicity in BALB/c Mice. AAPS PharmSciTech 25 (3) (2024)
Kanwal Khalid, Hui Xuan Lim, Ayaz Anwar, Soon Hao Tan, Jung Shan Hwang, Seng-Kai Ong, Chit Laa Poh
Preclinical Development of a Novel Epitope-based DNA Vaccine Candidate against SARS-CoV-2 and Evaluation of Immunogenicity in BALB/c Mice. AAPS PharmSciTech 25 (3) (2024)
Jia Sheng Yew, Seng-Kai Ong, Hui Xuan Lim, Soon Hao Tan, Kien Chai Ong, Kum Thong Wong, Chit Laa Poh
Immunogenicity of trivalent DNA vaccine candidate encapsulated in Chitosan-TPP nanoparticles against EV-A71 and CV-A16. Nanomedicine (London, England) (2024)
Jia Xuen Koh, Malihe Masomian, Mohd Ishtiaq Anasir, Seng-Kai Ong, Chit Laa Poh
Insights into In Vitro Adaptation of EV71 and Analysis of Reduced Virulence by In Silico Predictions. Vaccines 11 (3) (2023)
Abdul Aziz Al-Fattah Yahaya, Kanwal Khalid, Hui Xuan Lim, Chit Laa Poh
Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern. Viruses 15 (3) (2023)
Zhaoxuan Low, Rafidah Lani, Vunjia Tiong, Chit Laa Poh, Sazaly Abu Bakar, Pouya Hassandarvish
COVID-19 Therapeutic Potential of Natural Products. International journal of molecular sciences 24 (11) (2023)
Michelle Felicia Lee, Chit Laa Poh
Strategies to improve the physicochemical properties of peptide-based drugs. Pharmaceutical research (2023)
Michelle Felicia Lee, Chit Laa Poh
Strategies to improve the physicochemical properties of peptide-based drugs. Pharmaceutical research 40 (3) (2023)
Michelle Felicia Lee, Yuan Seng Wu, Chit Laa Poh
Molecular Mechanisms of Antiviral Agents against Dengue Virus. Viruses 15 (3) (2023)
Abdul Aziz Al-Fattah Yahaya, Kanwal Khalid, Hui Xuan Lim, Chit Laa Poh
Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern. Viruses 15 (3) (2023)
Michelle Felicia Lee, Yuan Seng Wu, Chit Laa Poh
Molecular Mechanisms of Antiviral Agents against Dengue Virus. Viruses 15 (3) (2023)
Michelle Felicia Lee, Yuan Seng Wu, Chit Laa Poh
Molecular Mechanisms of Antiviral Agents against Dengue Virus. Viruses 15 (3) (2023)
Abdul Aziz Al-Fattah Yahaya, Kanwal Khalid, Hui Xuan Lim, Chit Laa Poh
Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern. Viruses 15 (3) (2023)
Wen Tzuen Heng, Hui Xuan Lim, Kuan Onn Tan, Chit Laa Poh
Validation of Multi-epitope Peptides Encapsulated in PLGA Nanoparticles Against Influenza A Virus. Pharmaceutical research (2023)
Jia Xuen Koh, Malihe Masomian, Mohd Ishtiaq Anasir, Seng-Kai Ong, Chit Laa Poh
Insights into In Vitro Adaptation of EV71 and Analysis of Reduced Virulence by In Silico Predictions. Vaccines 11 (3) (2023)
Kanwal Khalid, Chit Laa Poh
The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria. Vaccines 11 (7) (2023)
Michelle Felicia Lee, Chit Laa Poh
Strategies to improve the physicochemical properties of peptide-based drugs. Pharmaceutical research 40 (3) (2023)
Chean Yeah Yong, Winnie Pui Pui Liew, Hui Kian Ong, Chit Laa Poh
Development of virus-like particles-based vaccines against coronaviruses. Biotechnology progress (2022)
Noraini Abd-Aziz, Chit Laa Poh
Development of Peptide-Based Vaccines for Cancer. Journal of oncology 2022 (2022)
Wen Tzuen Heng, Jia Sheng Yew, Chit Laa Poh
Nanovaccines against Viral Infectious Diseases. Pharmaceutics 14 (12) (2022)
Amrutha Menon, Noraini Abd-Aziz, Kanwal Khalid, Chit Laa Poh, Rakesh Naidu
miRNA: A Promising Therapeutic Target in Cancer. International journal of molecular sciences 23 (19) (2022)
Hui Xuan Lim, Malihe Masomian, Kanwal Khalid, Asqwin Uthaya Kumar, Paul A MacAry, Chit Laa Poh
Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting. International journal of molecular sciences 23 (8) (2022)
Wen Tzuen Heng, Jia Sheng Yew, Chit Laa Poh
Nanovaccines against Viral Infectious Diseases. Pharmaceutics 14 (12) (2022)
Wen Tzuen Heng, Jia Sheng Yew, Chit Laa Poh
Nanovaccines against Viral Infectious Diseases. Pharmaceutics 14 (12) (2022)
Bernadette Xin Jie Tune, Maw Shin Sim, Chit Laa Poh, Rhanye Mac Guad, Choy Ker Woon, Iswar Hazarika, Anju Das, Subash C B Gopinath, Mariappan Rajan, Mahendran Sekar, Vetriselvan Subramaniyan, Neeraj Kumar Fuloria, Shivkanya Fuloria, Kalaivani Batumalaie, Yuan Seng Wu
Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors. Journal of oncology 2022 (2022)
Ee Wern Tan, Noraini Abd-Aziz, Chit Laa Poh, Kuan-Onn Tan
Engineered Oncolytic Adenoviruses: An Emerging Approach for Cancer Therapy. Pathogens (Basel, Switzerland) 11 (10) (2022)
Mohd Ishtiaq Anasir, Chit Laa Poh
Discovery of B-cell epitopes for development of dengue vaccines and antibody therapeutics. Medical microbiology and immunology 211 (1) (2022)
Wen Tzuen Heng, Jia Sheng Yew, Chit Laa Poh
Nanovaccines against Viral Infectious Diseases. Pharmaceutics 14 (12) (2022)
Mohd Ishtiaq Anasir, Faisal Zarif, Chit Laa Poh
Antivirals blocking entry of enteroviruses and therapeutic potential. Journal of biomedical science 28 (1) (2021)
Malihe Masomian, Salima Lalani, Chit Laa Poh
Molecular Docking of SP40 Peptide towards Cellular Receptors for Enterovirus 71 (EV-A71). Molecules (Basel, Switzerland) 26 (21) (2021)
Hui Xuan Lim, Jianhua Lim, Chit Laa Poh
Identification and selection of immunodominant B and T cell epitopes for dengue multi-epitope-based vaccine. Medical microbiology and immunology 210 (1) (2021)
Salima Lalani, Malihe Masomian, Chit Laa Poh
Functional Insights into Silymarin as an Antiviral Agent against Enterovirus A71 (EV-A71). International journal of molecular sciences 22 (16) (2021)
Madiiha Bibi Mandary, Malihe Masomian, Seng-Kai Ong, Chit Laa Poh
Characterization of Plaque Variants and the Involvement of Quasi-Species in a Population of EV-A71. Viruses 12 (6) (2020)
Salima S Lalani, Mohd Ishtiaq Anasir, Chit Laa Poh
Antiviral activity of silymarin in comparison with baicalein against EV-A71. BMC complementary medicine and therapies 20 (1) (2020)
Malihe Masomian, Zuleeza Ahmad, Lai Ti Gew, Chit Laa Poh
Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection. Vaccines 8 (1) (2020)
Yanqi Chan, Seyed Davoud Jazayeri, Babu Ramanathan, Chit Laa Poh
Enhancement of Tetravalent Immune Responses to Highly Conserved Epitopes of a Dengue Peptide Vaccine Conjugated to Polystyrene Nanoparticles. Vaccines 8 (3) (2020)
Rui Rui Wong, Noraini Abd-Aziz, Sarah Affendi, Chit Laa Poh
Role of microRNAs in antiviral responses to dengue infection. Journal of biomedical science 27 (1) (2020)
Noraini Abd-Aziz, Nur Izyani Kamaruzman, Chit Laa Poh
Development of MicroRNAs as Potential Therapeutics against Cancer. Journal of oncology 2020 (2020)
Madiiha Bibi Mandary, Malihe Masomian, Chit Laa Poh
Impact of RNA Virus Evolution on Quasispecies Formation and Virulence. International journal of molecular sciences 20 (18) (2019)
Hui Xuan Lim, Chit Laa Poh
Insights into innate and adaptive immune responses in vaccine development against EV-A71. Therapeutic advances in vaccines and immunotherapy 7 (2019)
Mohd Ishtiaq Anasir, Chit Laa Poh
Advances in Antigenic Peptide-Based Vaccine and Neutralizing Antibodies against Viruses Causing Hand, Foot, and Mouth Disease. International journal of molecular sciences 20 (6) (2019)
Madiiha Bibi Mandary, Chit Laa Poh
Changes in the EV-A71 Genome through Recombination and Spontaneous Mutations: Impact on Virulence. Viruses 10 (6) (2018)

Chit Laa Poh.css-eqlu8i{font-size:small;padding-left:4px;} (Chitlaa Poh)

Publication Activity (10 Years)

Top Topics

Top Venues

Chit Laa Poh (Chitlaa Poh)